Furthermore, this study, for the first time, revealed the important functional interplay of a purinergic receptor P2Y11 and a chemokine receptor, CXCR4, in mediating the effect of ATP in inhibiting breast cancer bone metastasis. The gene discussed is CXCR4; the disease is breast cancer.